Prevalence
Causes
Clinical
features
Investigations
Therapy
Prevention
Prognosis
|  |  | | Therapy |
Inotropic agents
-
norepinephrine
c
(started if systolic blood pressure < 90 mmHg; 0.5 µg/kg/min with increments of 0.3 - 0.6 µg/kg/min to maintain
systolic bp >120/80)
There is no clear benefit from
dopamine a (low-dose: 1 - 3 µg/kg/min).
a

Why?
-
Norepinephrine infusion increases urine output, decreases creatinine levels and increases creatinine clearance in around 80% of patients with septic shock.
c
-
Norepinephrine stabilises more patients in hyperdynamic septic shock than dopamine
a
-
Dopamine acutely increases urine output and creatinine clearance in patients with oliguria or established acute renal failure.
b
-
The effect on requirement for dialysis, or death is unclear.
a
Norepinephrine stabilises septic shock better than dopamine
| Patient |
Treatment |
Comparison |
Outcome |
CER |
RRR (95% CI) |
NNT
(95% CI) |
hyperdynamic septic shock
a
|
norepinephrine
|
dopamine
|
haemodynamic
stabilisation for at least
at
6
hours
|
31%
|
200%
(43% to
530%)
|
2
(1 to
3)
|
|